Healthcare Associated Infections (HAI)

In an exclusive interview with Contagion®, Maureen Spencer, Accelerate Diagnostics, discusses different strategies to prevent and control C. difficile in health care facilities.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Richard Haupt, MD, MPH, explains the risk factors for Clostridium difficile infection.

A testing stewardship effort found that using a “hard stop” alert system may help reduce inappropriate C. difficile testing.

Paul Feuerstadt, MD, sheds light on the estimated burden of C. difficile infection in the United States.

Norman B. Javitt, MD, PhD, explains how antibiotics can impact bile acid composition and result in Clostridium difficile infection.

Barley Chironda, RPN, CIC, discusses current infection control measures taken to prevent C. difficile and the reasons why they are falling short.

Hospital employees are increasingly using hospital infection rates to highlight gaps in training, education, and staffing.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Roy F. Chemaly, MD, MPH, discusses the background behind letermovir and what it brings to the table.

An examination of broad-spectrum antibiotic use in this patient population is essential for developing strategies to mitigate the risk of these infections.

The growing threat of resistance and substantial costs for treating these infections accentuates the need for programs focused on appropriate treatment.

Contagion® will be providing exclusive coverage on the conference. Keep your eyes peeled for session coverage and interviews with some of the key presenters.

Can we track Clostridium difficile infections to see how patient movements result in exposures?

C. difficile prevention is usually thought of in terms of environmental disinfection and health care worker hand hygiene; what about the patient's role?

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Researchers from the University of Colorado Boulder have developed nanoparticles capable of boosting the effectiveness of antibiotics against drug-resistant superbugs.

A recent outbreak involving sterile medical supplies gives insight into a new hospital infectious disease threat.

A new study pulls back the curtain into a complex web of resistance, colonization, and the challenges of antimicrobial resistance in this setting.

A recent study found that a sepsis care bundle program implemented in The Mount Sinai Hospital in New York coincided with an increase in antibiotic prescriptions and higher rates of Clostridium difficile infections.

Prolonged antibiotic use opens the door to the development of antibiotic resistance, superinfections, and the risk of Clostridium difficile infections.

The message for clinicians is to be vigilant. Look for candidemia and C. difficile infection occurring together.

Using combination antifungal therapy for invasive mold diseases is still a grey area that remains to be supported by robust data and relies heavily on clinician assessment.